"Where Demands Meet Integrity and Challenges Find Solutions "
We Do What We Say and Say What We Do !
About REIWA Consulting GmbH
  • Founded by former C-level executive Kurt Stoeckli (ex SANOFI, Novartis, Glenmark), REIWA Consulting operates globally with focus on advisory services for the life sciences/healthcare sector
  • Partnering with pharmaceutical and MedTech companies, specialty pharma, NGOs, and network organisations to drive innovation, market access and commercial success
  • Helping biotech start-up's at both seed and/or scale-up stage
    (discovery, translational, clinical, fundraising, regulatory, and go-to-market strategies)
  • Strategic advisor to asset-centric financing projects in support of innovative life-science products (via BioVergence GmbH)
Mix of expertise, experience & networks
1
Hands-on experience in life sciences industry
Global R & D management
Business acumen
P&L responsibility
Management of major partnerships
CEO / CSO roles in biotech
2
Familar with pharma & biotech
TA head - Immunology & Inflammation (e.g. dupixent)
Divisional head biotherapeutics across TA’s from discovery to Ph3
Developed multifunctional modalities like bsAbs or ADCs (up to Ph2)
Founded & advised start-up’s
3
Advisory Boards & Consulting
Access to global networks of industry executives, academic institutions and KOL’s
Interacted with regulatory decision makers across major jurisdictions
Successful fundraising campaigns (VC, PE)
4
Proven track record
3 products from discovery to market and successful commercialisation
Multiple types of modalities from candidate to clinic stage (20+)
Initiated & steered major partnerships with significant outcome
Pioneered versatile platform technologies from pilot stage to commercial production
Consulting Services
1
Executive Solutions
Management consulting, temporary C-suite transitions to ensure continuity and excellence in leadership during transitions. Change management support
2
Strategy Projects
M&A projects, fundraising campaigns, corporate strategies, portfolio optimisation, evidence generation plans, regulatory roadmaps
3
Analyses & Assessment
Comprehensive due diligence, deep dives, risk assessments, gap analyses, and technology transfer projects
Client Success Stories
Portfolio Optimization
Helped companies review their portfolios and prioritize projects for maximum ROI and strategic alignment.
Strategic Roadmapping
Assisted clients in developing comprehensive 5-year strategic roadmaps inc. KPIs and implementation plans.
Innovation Strategy
Guided NGOs in establishing effective innovation strategies to maximize their impact in their ecosystem.
Change Management
Advised executive teams on implementing successful change management plans during critical transitions.
Consulting Approach
1
Problem Analysis
Stakeholder Feedback
Key Issue Mapping
Risk Analysis / Mitigation
2
Review & Research
Project & Literature Review
Scientific Quality | Gap Analysis
Competitive Landscape Analysis
3
Strategy Development
Purpose & Intent | Drivers & Enablers
Targets | Options | Scenarios
Initiatives | Critical Paths
4
Roadmap
Objectives | Milestones /KPI
Implementation | Resource Plans
Regulatory Path
5
Documentation
Executive Summaries
Reports
Presentations
6
Communication
Pitching Rounds | PR's
Supporting Material
Rehearsals
Deliverables
Quality Reports
DD / Scientific Reviews
Evidence Generation Plan
Strategic Roadmaps
with KPI & ROI indicators
Executive Presentations
e.g. to Investors, Management Boards or Regulators
Regulatory Strategies
FDA, EMA, MHRA
Roadmaps
Workshops / Webinars /
Trainings, Teambuildings, Rehearsals
Ad hoc advice
Team Support / Individual Support / Mentoring
Services / Representations
Helps international companies in founding Swiss affiliate
Supports networking / collaborative efforts in Europe/Switzerland
Areas of Expertise & Track Record
1
Therapeutic Modalities
  • Therapeutics antibodies
  • bi-/ tri-specific mAbs & ADCs
  • Small molecules (SMEs)
  • Nucleic acid therapeutics
  • Gene therapy (AAV, AV) & LNP
  • Cell Therapies (CAR-T, TILs)
—> Scientific review & support
2
Evidence Generation
  • Candidate selection & TPP
  • Translational & FIM strategy
  • Regulatory strategy (early dialogues, expedited paths, product designations)
  • IND/IMP dossier review
  • HTA support: relative effectiveness & market access
3
Areas of Expertise
  • Autoimmunity / Allergies
  • Chronic Inflammatory Diseases
  • Immunodermatology
  • Hematology / Oncology (TME)
  • Ophthalmology (IRDs)
  • Personalized Medicine / Digital Technologies / BioConvergence
Contact REIWA Consulting GmbH
Contact us today to schedule a consultation and discuss your strategic needs.
  • Dr. Kurt A. Stoeckli, Managing Director & Owner (LinkedIn)
  • Email: kurt.stoeckli@reiwacon.ch
  • REIWA Consulting GmbH
    Buttiweg 16 • CH-4112 Flueh • Switzerland
    (Basel Metropolitan Area)
    UID: CHE-320.022.360 (VAT)
Email Us
Basel
Pricing & Service Model
For more detailed information, please download the document below (pdf) and/or contact us directly to discuss further:

File upload

2025 REIWA Services .pdf

350.5 KB

" Where Demands Meet Integrity and Challenges Find Solutions"
Date: March 2026